You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Harvard Business School
Express Scripts
Boehringer Ingelheim

Last Updated: September 25, 2020

DrugPatentWatch Database Preview

Litigation Details for Valeant International, Bermuda v. Watson Pharmaceuticals Inc. (S.D. Fla. 2010)

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Small Molecule Drugs cited in Valeant International, Bermuda v. Watson Pharmaceuticals Inc.
The small molecule drugs covered by the patents cited in this case are   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial , and   Start Trial .

Details for Valeant International, Bermuda v. Watson Pharmaceuticals Inc. (S.D. Fla. 2010)

Date Filed Document No. Description Snippet Link To Document
2011-06-21 115 Regarding Validity of U.S. Patent Nos. 7,569,610, 7,563,823, 7,649,019, 7,572,… Notes re repeating example 1 of '706 patent LA … Notes re repeating example 1 of '706 patent LA … 71) PE 073 U.S. Patent Prosecution History File BIOVAIL-WAT741191… Information PE 080 2/8/2011 U.S. Patent No. 7,884,136 B2 External link to document
2011-07-29 140 DE 138 U.S. Patent No. 6,110,940 DE 139 U.S. Patent No. 6,110,973 to Young…from U.S. Patent File History No. 7,241,805 DE 013 Excerpts from U.S. Patent File History…from U.S. Patent File History No. 7,569,610 DE 015 Excerpts from U.S. Patent File History…from U.S. Patent File History No. 7,649,019 DE 017 Excerpts from U.S. Patent File History….S. Patent No. 7,553,992 [Chan Depo Ex. 062] DE 019 File History for U.S. Patent No. External link to document
2011-11-07 155 hydrochloride isU.S.PatentNo.6,110,940,filed May 17,1995 (the'tl-larding patent''). (Def. … subsequently patented by Mehta in 1974 in U.S.PatentNo.3,819.706 (the tkM ehta patent'').(Def.Ex…ingredient. Valeant owns four patents related to Aplenzinl : U.S. Patent Nos. 7,569,610, 7,563,823,…$610 patent;(2)Claim 9 ofthe:823patent;(3)Claim 10ofthe $823patent;(4)Claim 2 ofthe 1019 patent, …Moreover,whenthe Patent O ffice has considered the prior art during prosecution of the patents,the burden on External link to document
2011-11-08 158 problems with bupropion hydrochloride is U.S.PatentNo.6,110,940, tiled May 17,l995 (the Stl …ingredient. V aleant ow ns four patents rclated to A plenzin* : U .S. Patent N os. 7,569,610, 7,563,823,7,649,019…betweentheparties.Therepresentativeclaimsofthepatents-in-suitare:(1)Claim 3ofthe1610 patent;(2)Claim 9 ofthe$823 patent' … ,(3)Claim 10 ofthe;823 patent;(4)Claim 2 ofthe$019 patent;and (5)Claim 1ofthe1992patent.Thcrepresentativeclaimsrelatetocontrolledrelease…depression and was subsequently patented by M ehta in 1974 in (J.S.PatentNo.3,819,706 (the SkMehta patenf External link to document
2012-01-03 170 7,569,610 (the “‘610 patent”), 7,563,823 (the “‘823 patent”), and 7,649,019 (the “‘019 patent”). The other…Under Section 271(e) for the ‘992 Patent—A Patent Not Listed in the Orange Book—Is Improper…relief for infringement of U.S. Patent No. 7,553,992 (the “‘992 patent”). Such relief is not available… only to Orange Book 1 patents and Valeant chose not to list the ‘992 patent in the Orange Book. …competitors of which patents purportedly cover their drug products by listing those patents in the Orange External link to document
2012-02-23 189 shallnotbeadateearlierthan thelatestdateofexpiration ofU.S.PatentNos.7,569,610,7,649,019, and/or7,649,823. …2010 7 November 2011 1:10-cv-20526 830 Patent None District Court, S.D. Florida External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.